a public good project by the
Synthesis
Company
of California

© 2026

Neil Steven | doi.page

0 works0 citations0 h-index

Neil Steven

Swansea Bay University Health Board(GB)University Hospitals Birmingham NHS Foundation Trust(GB)University of Birmingham(GB)

Publications by Year

Research Areas

Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Viral-associated cancers and disorders, Immune Cell Function and Interaction

Most-Cited Works

→ Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo(1998)893 cited
→ A Phase I Study of OncoVEXGM-CSF, a Second-Generation Oncolytic Herpes Simplex Virus Expressing Granulocyte Macrophage Colony-Stimulating Factor(2006)565 cited
→ Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state(1994)492 cited
→ Large clonal expansions of CD8+ T cells in acute infectious mononucleosis(1996)481 cited
→ Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas(2005)421 cited
→ Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response(1997)350 cited

→ A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma†(2008)280 cited

→ Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma(2020)259 cited

→ Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing(1997)257 cited

→ A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors(2014)203 cited